Extensive evidence substantiates the involvement of IQGAP3 in the inception and progression of diverse malignant neoplasms, with notable prominence in breast cancer, clear cell renal cell carcinoma, and lung cancer [12–14]. Here, IQGAP3 is linked to clear cell renal carcinoma.